GE Healthcare Irel recalls

GE Healthcare Irel has 2 recalls on record with the FDA and USDA, the earliest in 2026 and the latest reported on 15 Apr 2026. 2 are still ongoing. 2 were reported in the last 12 months. The most frequent reason is particulate matter.

Total recalls2since 2026

Last 12 months2reported

Class I00% of total

Ongoing2latest 15 Apr 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 2Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 2 100%Class III 0 0%

Why ge healthcare irel is recalled

Particulate Matter2100%

Product types

Injectable & IV Drugs2100%

By year

20262100%

Ongoing ge healthcare irel recalls

2 active

Reported	Class	Recall	Company	Reason	Where
15 Apr 2026Drug	CLASS II	GE Healthcare Omnipaque (iohexol) Injection, 300 mg/mL (64.7%) recalledOmnipaque	GE Healthcare Irel	Particulate Matter	Nationwide
15 Apr 2026Drug	CLASS II	GE Healthcare Omnipaque (iohexol) Injection, 350 mg/mL (64.7%) recalledOmnipaque	GE Healthcare Irel	Particulate Matter	Nationwide

All ge healthcare irel recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
15 Apr 2026Drug	CLASS II	GE Healthcare Omnipaque (iohexol) Injection, 300 mg/mL (64.7%) recalledOmnipaque	GE Healthcare Irel	Particulate Matter	Nationwide
15 Apr 2026Drug	CLASS II	GE Healthcare Omnipaque (iohexol) Injection, 350 mg/mL (64.7%) recalledOmnipaque	GE Healthcare Irel	Particulate Matter	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.